MRL Ventures Fund — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Aktis Oncology discovers and develops targeted radiopharmaceuticals for treating solid tumors.
BiotechHealthtechMedical DevicesBoston, US
Todd Foley(Co-founder and Chairman)Patrick Baeuerle(Co-founder & Advisor)Shulamit Ron-Bigger(Executive Officer)
BoardHelen S. Kim(Director)Oleg Nodelman(Director)Andrew Levin(Director)
BiotechCambridge, US
Hui Tian(Executive Officer, Director)Madgalene Moran(Executive Officer, Director)
BoardBruce Bean(Director)James Jeffrey Goater, Jr.(Director)
Board seatKarin Kleinhans· per SEC Form D · $95M raise · filed Dec 2024
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.